A citation-based method for searching scientific literature

Julia Tchou, Seema S Sonnad, Meredith R Bergey, Sandip Basu, John Tomaszewski, Abass Alavi, Mitchell Schnall. Mol Imaging Biol 2010
Times Cited: 53







List of co-cited articles
289 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
208
33

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
237
33


Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
20

The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Wataru Shimoda, Mitsuhiro Hayashi, Koji Murakami, Tetsunari Oyama, Masakatsu Sunagawa. Breast Cancer 2007
71
18

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
183
18


Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
298
16

18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Hye Ryoung Koo, Jeong Seon Park, Keon Wook Kang, Nariya Cho, Jung Min Chang, Min Sun Bae, Won Hwa Kim, Su Hyun Lee, Mi Young Kim, Jin You Kim,[...]. Eur Radiol 2014
57
16

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida,[...]. Jpn J Clin Oncol 2008
151
15

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Reinhard Bos, Jacobus J M van Der Hoeven, Elsken van Der Wall, Petra van Der Groep, Paul J van Diest, Emile F I Comans, Urvi Joshi, Gregg L Semenza, Otto S Hoekstra, Adriaan A Lammertsma,[...]. J Clin Oncol 2002
405
15


Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
13

Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
112
13

Increased FDG uptake in breast cancer is associated with prognostic factors.
Yasemin Sanli, Serkan Kuyumcu, Zeynep Gozde Ozkan, Göknur Işik, Hasan Karanlik, Burcu Guzelbey, Cuneyt Turkmen, Sevda Ozel, Ekrem Yavuz, Ayse Mudun. Ann Nucl Med 2012
46
15

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
128
13

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
11

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
348
11

Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
F Crippa, E Seregni, R Agresti, C Chiesa, C Pascali, A Bogni, D Decise, V De Sanctis, M Greco, M G Daidone,[...]. Eur J Nucl Med 1998
134
11

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Pierre Heudel, Sebastien Cimarelli, Anthony Montella, Catherine Bouteille, Thomas Mognetti. Int J Clin Oncol 2010
54
11

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, E H Lips, W V Vogel, T S Aukema, E van Werkhoven, K G A Gilhuijs, S Rodenhuis, E J Th Rutgers,[...]. Eur J Nucl Med Mol Imaging 2012
63
11

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
9

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
David Groheux, Jean-Luc Moretti, Georges Baillet, Marc Espie, Sylvie Giacchetti, Elif Hindie, Christophe Hennequin, Jacques-Robert Vilcoq, Caroline Cuvier, Marie-Elisabeth Toubert,[...]. Int J Radiat Oncol Biol Phys 2008
85
9

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose.
M Oshida, K Uno, M Suzuki, T Nagashima, H Hashimoto, H Yagata, T Shishikura, K Imazeki, N Nakajima. Cancer 1998
178
9

Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
Ana María García Vicente, Ángel Soriano Castrejón, Alberto León Martín, Ignacio Chacón López-Muñiz, Vicente Muñoz Madero, María del Mar Muñoz Sánchez, Azahara Palomar Muñoz, Ruth Espinosa Aunión, Ana González Ageitos. Eur J Nucl Med Mol Imaging 2013
41
12

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.
Alina Berriolo-Riedinger, Claude Touzery, Jean-Marc Riedinger, Michel Toubeau, Bruno Coudert, Laurent Arnould, Christophe Boichot, Alexandre Cochet, Pierre Fumoleau, François Brunotte. Eur J Nucl Med Mol Imaging 2007
129
9

Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Kathleen I Pritchard, Jim A Julian, Claire M B Holloway, David McCready, Karen Yvonne Gulenchyn, Ralph George, Nicole Hodgson, Peter Lovrics, Francisco Perera, Leela Elavathil,[...]. J Clin Oncol 2012
52
9

Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
Alexandre Cochet, Sophie Pigeonnat, Blandine Khoury, Jean-Marc Vrigneaud, Claude Touzery, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Michel Toubeau, Olivier Humbert, Bruno Coudert,[...]. J Nucl Med 2012
37
13

18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Joseph R Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B Cook, Steven Larson. J Nucl Med 2010
71
9

Performance of FDG PET/CT in the clinical management of breast cancer.
David Groheux, Marc Espié, Sylvie Giacchetti, Elif Hindié. Radiology 2013
140
9

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
David Groheux, Elif Hindié, Marc Delord, Sylvie Giacchetti, Anne-sophie Hamy, Cédric de Bazelaire, Anne de Roquancourt, Laetitia Vercellino, Marie-Elisabeth Toubert, Pascal Merlet,[...]. J Natl Cancer Inst 2012
89
9

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Masahiro Ohara, Hideo Shigematsu, Yasuhiro Tsutani, Akiko Emi, Norio Masumoto, Shinji Ozaki, Takayuki Kadoya, Morihito Okada. Breast 2013
33
15

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.
David Groheux, Elif Hindié, Sylvie Giacchetti, Anne-Sophie Hamy, Frederique Berger, Pascal Merlet, Anne de Roquancourt, Patricia de Cremoux, Michel Marty, Mathieu Hatt,[...]. Eur J Cancer 2014
37
13


Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.
Hye Ryoung Koo, Jeong Seon Park, Keon Wook Kang, Wonshik Han, In Ae Park, Woo Kyung Moon. Eur Radiol 2015
23
21

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred, Richard J Cote, Mitchell Dowsett, Patrick L Fitzgibbons, Wedad M Hanna, Amy Langer,[...]. J Clin Oncol 2007
7

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
7

Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
7

Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
Takayoshi Uematsu, Masako Kasami, Sachiko Yuen. Radiology 2009
202
7


Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma.
Xingchen Wu, Hannu Pertovaara, Pasi Korkola, Martine Vornanen, Hannu Eskola, Pirkko-Liisa Kellokumpu-Lehtinen. Leuk Lymphoma 2012
22
18

Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.
K L Cooper, S Harnan, Y Meng, S E Ward, P Fitzgerald, D Papaioannou, L Wyld, C Ingram, I D Wilkinson, E Lorenz. Eur J Surg Oncol 2011
73
7

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
Bhumsuk Keam, Seock-Ah Im, Youngil Koh, Sae-Won Han, Do-Youn Oh, Nariya Cho, Jee Hyun Kim, Wonshik Han, Keon Wook Kang, Woo Kyung Moon,[...]. BMC Cancer 2011
42
9

False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
Margaret Adejolu, Lei Huo, Eric Rohren, Lumarie Santiago, Wei T Yang. AJR Am J Roentgenol 2012
71
7

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
F Dehdashti, J E Mortimer, B A Siegel, L K Griffeth, T J Bonasera, M J Fusselman, D D Detert, P D Cutler, J A Katzenellenbogen, M J Welch. J Nucl Med 1995
250
7

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies.
S Fasanella, E Leonardi, C Cantaloni, C Eccher, I Bazzanella, D Aldovini, E Bragantini, L Morelli, L V Cuorvo, A Ferro,[...]. Diagn Pathol 2011
75
7

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Bas B Koolen, Marie-Jeanne T F D Vrancken Peeters, Tjeerd S Aukema, Wouter V Vogel, Hester S A Oldenburg, Jos A van der Hage, Cornelis A Hoefnagel, Marcel P M Stokkel, Claudette E Loo, Sjoerd Rodenhuis,[...]. Breast Cancer Res Treat 2012
85
7

The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.
David Groheux, Sylvie Giacchetti, Marc Espié, Laetitia Vercellino, Anne-Sophie Hamy, Marc Delord, Nathalie Berenger, Marie-Elisabeth Toubert, Jean-Louis Misset, Elif Hindié. J Nucl Med 2011
62
7

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
T S Aukema, E J Th Rutgers, W V Vogel, H J Teertstra, H S Oldenburg, M T F D Vrancken Peeters, J Wesseling, N S Russell, R A Valdés Olmos. Eur J Surg Oncol 2010
60
7

Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Patrick G Morris, Gary A Ulaner, Anne Eaton, Maurizio Fazio, Komal Jhaveri, Sujata Patil, Laura Evangelista, Joseph Y Park, Cristian Serna-Tamayo, Jane Howard,[...]. Cancer 2012
46
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.